Singapore markets closed
Straits Times Index
3,338.94 -9.93 (-0.30%) S&P 500
5,283.40 +5.89 (+0.11%) Dow
38,571.03 -115.27 (-0.30%) Nasdaq
16,828.67 +93.67 (+0.56%) Bitcoin USD
69,004.97 -624.87 (-0.90%) CMC Crypto 200
1,443.53 -3.62 (-0.25%)
Xenon Pharmaceuticals Inc. (XENE)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 2.90B |
| Enterprise value | 2.21B |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | N/A |
| Price/book (mrq) | 3.26 |
| Enterprise value/revenue | 10.87k |
| Enterprise value/EBITDA | N/A |
Trading information
Stock price history
| Beta (5Y monthly) | N/A |
| 52-week change 3 | -3.92% |
| S&P500 52-week change 3 | 23.33% |
| 52-week high 3 | 50.99 |
| 52-week low 3 | 27.99 |
| 50-day moving average 3 | 41.15 |
| 200-day moving average 3 | 40.13 |
Share statistics
| Avg vol (3-month) 3 | 339.51k |
| Avg vol (10-day) 3 | 406.64k |
| Shares outstanding 5 | 75.47M |
| Implied shares outstanding 6 | 75.47M |
| Float 8 | 69.56M |
| % held by insiders 1 | 0.38% |
| % held by institutions 1 | 100.64% |
| Shares short (15 May 2024) 4 | 2.82M |
| Short ratio (15 May 2024) 4 | 8.39 |
| Short % of float (15 May 2024) 4 | 3.76% |
| Short % of shares outstanding (15 May 2024) 4 | 3.73% |
| Shares short (prior month 15 Apr 2024) 4 | 2.62M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Mar 2024 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | 0.00% |
Management effectiveness
| Return on assets (ttm) | -17.09% |
| Return on equity (ttm) | -23.95% |
Income statement
| Revenue (ttm) | N/A |
| Revenue per share (ttm) | N/A |
| Quarterly revenue growth (yoy) | N/A |
| Gross profit (ttm) | N/A |
| EBITDA | -219.97M |
| Net income avi to common (ttm) | -188.6M |
| Diluted EPS (ttm) | -2.72 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 699.6M |
| Total cash per share (mrq) | 9.27 |
| Total debt (mrq) | N/A |
| Total debt/equity (mrq) | N/A |
| Current ratio (mrq) | 31.82 |
| Book value per share (mrq) | 11.78 |
Cash flow statement
| Operating cash flow (ttm) | N/A |
| Levered free cash flow (ttm) | N/A |
© 2024 Yahoo. All rights reserved.